Bryony Dawkins

Using Cost-Effectiveness Analysis to Address Health Equity Concerns

Richard Cookson, Andrew J. Mirelman, Susan Griffin et al. · Value in Health · 2017 · 291 citations · Full text

Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy

Kate Absolom, Lorraine Warrington, Eleanor Hudson et al. · Journal of Clinical Oncology · 2021 · 271 citations

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Mark T. Drayson, Stella Bowcock, Tim Planche et al. · The Lancet Oncology · 2019 · 151 citations · Full text

Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia

Bryony Dawkins, Andrew J. Mirelman, Miqdad Asaria et al. · Health Policy and Planning · 2017 · 45 citations · Full text

Distributional Cost-effectiveness Analysis, Health Disparities, Health Inequality Impacts +24

Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT

Sarah Brown, Colin Everett, Kamran Naraghi et al. · Health Technology Assessment · 2018 · 33 citations · Full text